a Division of Forensic Medicine , University of Florida College of Medicine , Gainesville , Florida , USA.
J Addict Dis. 2013;32(3):231-43. doi: 10.1080/10550887.2013.824334.
Deaths involving prescription and illicit opioids are on the rise, which is an issue of increasing concern to health care professionals, policymakers, and the public. However, because medical examiners, coroners, and other practitioners do not use uniform standards and case definitions in classifying such drug-related deaths, the incidence and prevalence data are challenging to analyze and difficult to interpret, and thus form a poor basis for crafting effective responses. To address this situation, the Substance Abuse and Mental Health Services Administration convened a Consensus Panel and charged it with devising uniform standards and case definitions that can assist medical examiners, coroners, public health officials, and others in consistently distinguishing between deaths that were caused by a certain opioids and deaths in which such a drug was detected but was not a major cause of or contributor to the death. The consensus statement presented here incorporates the panel's recommendations in four key areas.
涉及处方和非法阿片类药物的死亡人数正在上升,这是医疗保健专业人员、政策制定者和公众日益关注的问题。然而,由于法医、验尸官和其他从业者在分类此类药物相关死亡时没有使用统一的标准和案例定义,因此发病率和流行率数据难以分析和解释,从而无法为制定有效应对措施提供良好基础。为了解决这一问题,滥用药物和心理健康服务管理局召集了一个共识小组,并责成其制定统一的标准和案例定义,以帮助法医、验尸官、公共卫生官员和其他人员始终如一地区分因特定阿片类药物导致的死亡和在这些药物被检测到但不是主要死因或促成因素的死亡。这里提出的共识声明包含了专家组在四个关键领域的建议。